Diakos CI - Search Results

1

Differential effects of radiation fractionation regimens on glioblastoma.

McKelvey KJ, Hudson AL, Donaghy H, Stoner SP, Wheeler HR, Diakos CI, Howell VM. McKelvey KJ, et al. Among authors: diakos ci. Radiat Oncol. 2022 Jan 25;17(1):17. doi: 10.1186/s13014-022-01990-y. Radiat Oncol. 2022. PMID: 35073960 Free PMC article.

2

Radiation, inflammation and the immune response in cancer.

McKelvey KJ, Hudson AL, Back M, Eade T, Diakos CI. McKelvey KJ, et al. Among authors: diakos ci. Mamm Genome. 2018 Dec;29(11-12):843-865. doi: 10.1007/s00335-018-9777-0. Epub 2018 Sep 3. Mamm Genome. 2018. PMID: 30178305 Free PMC article. Review.

3

Sub-acute Toxicity in Non-cancerous Tissue and Immune-Related Adverse Events of a Novel Combination Therapy for Cancer.

McKelvey KJ, Hudson AL, Prasanna Kumar R, Eade T, Clarke SJ, Wheeler HR, Diakos CI, Howell VM. McKelvey KJ, et al. Among authors: diakos ci. Front Oncol. 2020 Jan 14;9:1504. doi: 10.3389/fonc.2019.01504. eCollection 2019. Front Oncol. 2020. PMID: 32010614 Free PMC article.

4

Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model.

McKelvey KJ, Hudson AL, Prasanna Kumar R, Wilmott JS, Attrill GH, Long GV, Scolyer RA, Clarke SJ, Wheeler HR, Diakos CI, Howell VM. McKelvey KJ, et al. Among authors: diakos ci. PLoS One. 2020 Apr 2;15(4):e0226444. doi: 10.1371/journal.pone.0226444. eCollection 2020. PLoS One. 2020. PMID: 32240177 Free PMC article.

5

Are In Vitro Human Blood-Brain-Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?

Prashanth A, Donaghy H, Stoner SP, Hudson AL, Wheeler HR, Diakos CI, Howell VM, Grau GE, McKelvey KJ. Prashanth A, et al. Among authors: diakos ci. Cancers (Basel). 2021 Feb 25;13(5):955. doi: 10.3390/cancers13050955. Cancers (Basel). 2021. PMID: 33668807 Free PMC article. Review.

6

Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma.

McKelvey KJ, Wilson EB, Short S, Melcher AA, Biggs M, Diakos CI, Howell VM. McKelvey KJ, et al. Among authors: diakos ci. Front Oncol. 2021 Mar 29;11:633210. doi: 10.3389/fonc.2021.633210. eCollection 2021. Front Oncol. 2021. PMID: 33854970 Free PMC article.

7

The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer.

Maloney S, Pavlakis N, Itchins M, Arena J, Mittal A, Hudson A, Colvin E, Sahni S, Diakos C, Chan D, Gill AJ, Samra J, Clarke SJ. Maloney S, et al. J Clin Med. 2023 Mar 2;12(5):1989. doi: 10.3390/jcm12051989. J Clin Med. 2023. PMID: 36902776 Free PMC article.

8

Cancer-related inflammation and treatment effectiveness.

Diakos CI, Charles KA, McMillan DC, Clarke SJ. Diakos CI, et al. Lancet Oncol. 2014 Oct;15(11):e493-503. doi: 10.1016/S1470-2045(14)70263-3. Lancet Oncol. 2014. PMID: 25281468 Review.

9

Shinko D, Diakos CI, Clarke SJ, Charles KA. Shinko D, et al. Among authors: diakos ci. Clin Pharmacol Ther. 2017 Oct;102(4):599-610. doi: 10.1002/cpt.789. Epub 2017 Aug 24. Clin Pharmacol Ther. 2017. PMID: 28699186 Review.

10

Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy.

Wijetunga AR, Chua TC, Nahm CB, Pavlakis N, Clarke S, Chan DL, Diakos C, Maloney S, Ashrafi-Zadeh A, Kneebone A, Hruby G, Jamieson NB, Gill A, Mittal A, Samra JS. Wijetunga AR, et al. Eur J Surg Oncol. 2021 Oct;47(10):2543-2550. doi: 10.1016/j.ejso.2021.04.005. Epub 2021 Apr 30. Eur J Surg Oncol. 2021. PMID: 33952409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page